KPIs & Operating Metrics(New)
Growth Metrics

Astrazeneca (AZN) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Astrazeneca (AZN) over the last 17 years, with Q4 2025 value amounting to $59.1 billion.

  • Astrazeneca's Goodwill & Intangibles rose 152.23% to $59.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $59.1 billion, marking a year-over-year increase of 152.23%. This contributed to the annual value of $59.1 billion for FY2025, which is 152.23% up from last year.
  • According to the latest figures from Q4 2025, Astrazeneca's Goodwill & Intangibles is $59.1 billion, which was up 152.23% from $59.4 billion recorded in Q3 2025.
  • In the past 5 years, Astrazeneca's Goodwill & Intangibles ranged from a high of $90.9 billion in Q4 2021 and a low of $31.8 billion during Q2 2021
  • In the last 5 years, Astrazeneca's Goodwill & Intangibles had a median value of $59.1 billion in 2022 and averaged $58.3 billion.
  • In the last 5 years, Astrazeneca's Goodwill & Intangibles surged by 26155.96% in 2021 and then tumbled by 3498.53% in 2022.
  • Over the past 5 years, Astrazeneca's Goodwill & Intangibles (Quarter) stood at $90.9 billion in 2021, then plummeted by 34.99% to $59.1 billion in 2022, then fell by 1.67% to $58.1 billion in 2023, then rose by 0.11% to $58.2 billion in 2024, then rose by 1.52% to $59.1 billion in 2025.
  • Its Goodwill & Intangibles was $59.1 billion in Q4 2025, compared to $59.4 billion in Q3 2025 and $59.1 billion in Q2 2025.